Evidence map›Paper›PMID 41331316›Full record

ArticleScientific reports2025

Influence of ageing of graphene oxide on the properties and morphology of cement mortar.

Suganthiny Ganesh, Charitha Thambiliyagodage, S V T Janaka Perera, R K N D Rajapakse

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suganthiny GaneshDepartment of Civil Engineering, Faculty of Engineering, Sri Lanka Institute of Information Technology, Colombo, 10115, Sri Lanka.
Charitha ThambiliyagodageDepartment of Applied Sciences, Faculty of Humanities and Sciences, Sri Lanka Institute of Information Technology, Colombo, 10115, Sri Lanka.
S V T Janaka PereraDepartment of Civil Engineering, Faculty of Engineering, Sri Lanka Institute of Information Technology, Colombo, 10115, Sri Lanka.
R K N D RajapakseDepartment of Civil Engineering, Faculty of Engineering, Sri Lanka Institute of Information Technology, Colombo, 10115, Sri Lanka. rajapakse@sfu.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Past studies show that Graphene Oxide (GO) enhances the structural properties of cement composites. However, GO reduces its chemical characteristics with ageing. This study determines the effects of the age of commercial and laboratory-produced GO on cementitious composites. The study considered GO of up to 35 weeks of age, and specimens were chemically characterised using various techniques. The ageing effects were evaluated using consistency, initial setting time, compressive strength, splitting tensile strength, and water absorption. The composite's thermal resistance was also tested. GO was found to have a shelf life of 13 weeks from production to achieve favourable results. The morphology of the cement mortar was studied to determine the reason for the change in performance with GO age. This study confirms that the carbon-to-oxygen ratio (C/O) and the disorder of graphene oxide sheets (ID/IG ratio), along with the number of GO layers, govern the performance of GO-incorporated cement composites. Both ratios increase with GO age. Aged GOs in mortar increased the mean pore radius and reduced the surface area. Mortar samples with aged GOs have ettringite peaks, while early-age GO-containing samples lack ettringite peaks. Despite reduced mechanical performance with age, all mortar samples remained thermally stable at higher temperatures.

Indexed as

AgeingCementGraphene oxideMorphologyNanotechnologyStrength

Identifiers

PMID41331316
PMCPMC12780010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.